2015
DOI: 10.1515/labmed-2015-0038
|View full text |Cite
|
Sign up to set email alerts
|

Role of ischemia-modified albumin in clinical practice

Abstract: Difficulty in establishing a diagnosis of acute coronary syndrome (ACS) in the clinical setting has led researchers to investigate novel markers that show increased blood levels before the myocardial necrosis occurs. In ischemic conditions, some modifications occur in the amino acids located on the N-terminus of the human albumin molecule. Ischemia-modified albumin (IMA) is a marker formed after damage in the N-terminal region of albumin. The altered N-terminus can no longer bind transition metals, such as cob… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
6
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 54 publications
0
6
0
Order By: Relevance
“…A number of diseases associated with oxidative stress and the necrotic death of myocardial cells manifest themselves in extracellular Mb and ischemically modified albumin [34,37,38,73,74]. The interaction of serum albumin and hypervalent Mb forms can occur during rhabdomyolysis and ischemic myocardial damage [74][75][76]. This process can also be associated with skeletal muscle ischemia.…”
Section: Discussionmentioning
confidence: 99%
“…A number of diseases associated with oxidative stress and the necrotic death of myocardial cells manifest themselves in extracellular Mb and ischemically modified albumin [34,37,38,73,74]. The interaction of serum albumin and hypervalent Mb forms can occur during rhabdomyolysis and ischemic myocardial damage [74][75][76]. This process can also be associated with skeletal muscle ischemia.…”
Section: Discussionmentioning
confidence: 99%
“…Based on the degree of interaction between IMA and metal ions especially cobalt (Co 2+ ), assays quantifying IMA known as the Albumin Cobalt Binding (ACB) test are used [ 35 , 39 – 41 ]. This test measures IMA in human serum and it is reliable for the early detection of myocardial ischemia [ 40 – 42 ]. Importantly, the ACB test is sensitive to changes in IMA concentration (6–10 min after ischemia) that remain high for 6 h, which contributes to its reliable clinical utility [ 40 ].…”
Section: Discussionmentioning
confidence: 99%
“…This test measures IMA in human serum and it is reliable for the early detection of myocardial ischemia [ 40 – 42 ]. Importantly, the ACB test is sensitive to changes in IMA concentration (6–10 min after ischemia) that remain high for 6 h, which contributes to its reliable clinical utility [ 40 ]. Thus, IMA is also important in the accurate and timely diagnosis of different ischemia-related diseases [ 35 , 39 – 41 ].…”
Section: Discussionmentioning
confidence: 99%
“…Serum IMA has been studied in myocardial infarction, acute coronary syndrome, sepsis, pulmonary embolism, deep vein thrombosis, cerebrovascular disease, carbon mono oxide poisoning, end stage renal disease, chronic hepatitis C, diabetes mellitus, hypertension, and much more. 13 Serum IMA has also been considered as novel biomarker of endothelial damage in diabetic patients. 14 The present research group has also studied serum IMA as an early biomarker in epilepsy.…”
Section: Discussionmentioning
confidence: 99%